Question 1

What was CARE Ratings' net profit in Q2 FY27?

Accepted Answer

Consolidated net profit attributable to shareholders was ₹71.8 crore, up 26.8% from ₹56.7 crore in Q2 FY26 and up 122.7% from ₹32.3 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹72.4 crore.

Question 2

How were CARE Ratings' Q2 FY27 results?

Accepted Answer

Both grew from a year earlier: net profit was up 26.8% at ₹71.8 crore and revenue was up 20.4% at ₹164 crore. The operating margin was 49.2%, up 1.6 percentage points from 47.6% a year earlier. Against Q1 FY27, net profit was up 122.7% and revenue up 47.0%.

Question 3

What was CARE Ratings' net profit in FY26?

Accepted Answer

Consolidated net profit attributable to shareholders was ₹171 crore in FY26 (April 2025–March 2026), up 24.7% from ₹137 crore in FY25. It was ₹101 crore in FY24 and ₹82.7 crore in FY23: up 107.1% over three years, 27.5% a year on average.

Question 4

What was CARE Ratings' revenue in Q2 FY27?

Accepted Answer

Revenue from operations was ₹164 crore, up 20.4% year on year and up 47.0% from the previous quarter.

Question 5

What was CARE Ratings' EPS in Q2 FY27?

Accepted Answer

Basic earnings per share were ₹23.88, against ₹18.90 in Q2 FY26.

Question 6

What is CARE Ratings' net profit margin?

Accepted Answer

CARE Ratings' net profit margin was 43.8% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations), against 41.6% in Q2 FY26 (up 2.2 percentage points). For FY26 as a whole it was 36.2%.

Question 7

What was CARE Ratings' operating margin in Q2 FY27?

Accepted Answer

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹80.8 crore, a margin of 49.2%, against 27.6% in Q1 FY27 and 47.6% in Q2 FY26. EBITDA was ₹84.6 crore, 51.6% of revenue.

Question 8

What was CARE Ratings' net profit in the first half of FY27?

Accepted Answer

Consolidated net profit attributable to shareholders for the first half of FY27 (April–September 2026) was ₹104 crore, up 26.3% from ₹82.4 crore in the same months a year earlier. Revenue from operations was ₹276 crore, up 19.8%.

Question 9

How has CARE Ratings' profit changed over the last four quarters?

Accepted Answer

Net profit attributable to shareholders by quarter: ₹35.9 crore in Q3 FY26, ₹52.8 crore in Q4 FY26, ₹32.3 crore in Q1 FY27 and ₹71.8 crore in Q2 FY27. That is ₹193 crore over the four quarters, up 26.2% from ₹153 crore in the four quarters before. Revenue from operations: ₹112 crore, ₹131 crore, ₹112 crore and ₹164 crore.

Question 10

What was CARE Ratings' revenue in FY26?

Accepted Answer

Revenue from operations was ₹473 crore in FY26 (April 2025–March 2026), up 17.6% from ₹402 crore in FY25. It was ₹332 crore in FY24 and ₹279 crore in FY23: up 69.6% over three years, 19.2% a year on average.

Question 11

When did CARE Ratings announce its Q2 FY27 results?

Accepted Answer

On Thursday, 29 October 2026 at 8:06 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 12 November 2025.

Question 12

Did CARE Ratings declare a dividend with its Q2 FY27 results?

Accepted Answer

Yes. The board declared an interim dividend of ₹10 per share on 29 October 2026. The record date is 6 November 2026.

Question 13

When will CARE Ratings announce its Q3 FY27 results?

Accepted Answer

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Question 14

Where do these CARE Ratings figures come from?

Accepted Answer

From CARE Ratings' own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 29 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	164	136	+20.4%
EBITDA	84.6	68.4	+23.7%
EBITDA margin	51.6%	50.2%	+1.4 pts
Profit before tax	95.6	76.9	+24.3%
Net profit	72.4	57.2	+26.5%
EPS	₹23.88	₹18.90	+26.3%

Expenses
	164	112	131	112	136	93.9	110	96.4	117	78.9	90.1	78.7	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	15.4	14.8	15.7	13.0	12.6	13.7	15.2	11.9	11.9	11.9	10.3	13.7
	180	126	146	125	149	108	125	108	129	90.8	100	92.4
	60.7	59.2	52.6	55.1	53.3	53.7	47.1	50.3	45.7	45.7	43.2	42.5
	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.5	0.5	0.5	0.5
	3.9	3.9	3.8	3.7	3.5	3.4	3.1	3.0	2.9	2.8	2.7	2.6
	18.8	17.9	17.4	16.7	14.7	12.5	15.2	15.6	15.9	11.4	17.9	12.8
	84.0	81.5	74.4	76.1	72.0	70.2	65.9	69.5	65.0	60.4	64.2	58.4
	84.6	34.6	60.8	40.3	68.4	27.7	47.4	30.4	55.7	21.8	29.0	23.4
	80.8	30.8	56.9	36.7	64.9	24.3	44.3	27.4	52.9	19.0	26.4	20.8
Profit
	95.6	45.0	72.0	49.0	76.9	37.4	58.9	38.7	64.2	30.4	36.2	34.0
	95.6	45.0	72.0	49.0	76.9	37.4	58.9	38.7	64.2	30.4	36.2	34.0
	23.6	13.1	18.8	13.3	19.7	10.4	14.2	11.1	17.7	8.6	11.3	10.2
	−0.4	−1.1	−0.2	−0.9	0.0	0.5	1.3	−0.8	−0.3	0.4	0.4	−0.1
	23.2	12.0	18.6	12.5	19.7	10.9	15.5	10.4	17.4	9.0	11.6	10.0
	72.4	33.0	53.4	36.5	57.2	26.5	43.4	28.4	46.9	21.4	24.6	23.9
	72.4	33.0	53.4	36.5	57.2	26.5	43.4	28.4	46.9	21.4	24.6	23.9
	0.6	−0.1	1.6	0.1	1.2	−0.4	0.3	0.4	−1.0	0.1	−0.1	−0.3
	73.0	32.9	55.1	36.7	58.4	26.1	43.6	28.7	45.8	21.5	24.5	23.7
	71.8	32.3	52.8	35.9	56.7	25.8	42.6	27.8	46.1	20.7	24.1	23.5
	0.5	0.7	0.6	0.6	0.5	0.7	0.8	0.6	0.8	0.6	0.5	0.5
Per share
	₹23.88	₹10.73	₹17.58	₹11.96	₹18.90	₹8.61	₹14.24	₹9.30	₹15.42	₹6.94	₹8.07	₹7.88
	₹23.82	₹10.70	₹17.51	₹11.91	₹18.81	₹8.57	₹14.17	₹9.24	₹15.36	₹6.91	₹8.03	₹7.85
Other comprehensive income — detail
	0.6	−0.1	1.6	0.1	1.2	−0.4	0.3	—	—	—	—	—
	0.3	−0.3	0.3	−0.1	0.1	−0.4	0.4	−0.3	−0.5	0.1	−0.2	−0.4
	0.1	−0.0	0.1	−0.0	0.0	−0.1	0.1	—	—	—	—	—
	—	—	—	—	—	—	—	−0.1	0.6	−0.0	−0.3	−0.1
	0.4	0.2	1.4	0.2	1.1	−0.1	−0.1	0.6	0.1	0.0	−0.1	0.0
	72.5	32.1	54.4	36.1	57.8	25.4	42.9	28.2	45.0	20.9	24.1	23.2
	0.5	0.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.7	0.4	0.5
Per share — as-filed variants
	₹23.88	₹10.73	₹17.58	₹11.96	₹18.90	₹8.61	₹14.24	₹9.30	₹15.42	₹6.94	₹8.07	₹7.88
	₹23.82	₹10.70	₹17.51	₹11.91	₹18.81	₹8.57	₹14.17	₹9.24	₹15.36	₹6.91	₹8.03	₹7.85
Adjusted (ex-exceptional items) — derived
	95.6	45.0	72.0	49.0	76.9	37.4	58.9	38.7	64.2	30.4	36.2	34.0
	72.4	33.0	53.4	36.5	57.2	26.5	43.4	28.4	46.9	21.4	24.6	23.9
	₹23.88	₹10.73	₹17.58	₹11.96	₹18.90	₹8.61	₹14.24	₹9.30	₹15.42	₹6.94	₹8.07	₹7.88

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	78.7	90.1	78.9	117.4	96.4	109.7	93.9	136.4	112.1	130.7	111.7	164.1
Other Income	13.7	10.3	11.9	11.9	11.9	15.2	13.7	12.6	13.0	15.7	14.8	15.4
Total Income	92.4	100.4	90.8	129.2	108.2	124.8	107.6	148.9	125.1	146.4	126.5	179.6
Expenses
+ Employee Benefit Expense	42.5	43.2	45.7	45.7	50.3	47.1	53.7	53.3	55.1	52.6	59.2	60.7
+ Finance Costs	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6
+ Depreciation & Amortisation	2.6	2.7	2.8	2.9	3.0	3.1	3.4	3.5	3.7	3.8	3.9	3.9
+ Other Expenses	12.8	17.9	11.4	15.9	15.6	15.2	12.5	14.7	16.7	17.4	17.9	18.8
Total Expenses	58.4	64.2	60.4	65.0	69.5	65.9	70.2	72.0	76.1	74.4	81.5	84.0
EBITDA	23.4	29.0	21.8	55.7	30.4	47.4	27.7	68.4	40.3	60.8	34.6	84.6
EBIT	20.8	26.4	19.0	52.9	27.4	44.3	24.3	64.9	36.7	56.9	30.8	80.8
Profit
PBT before Exceptional Items	34.0	36.2	30.4	64.2	38.7	58.9	37.4	76.9	49.0	72.0	45.0	95.6
Pretax Income	34.0	36.2	30.4	64.2	38.7	58.9	37.4	76.9	49.0	72.0	45.0	95.6
+ Current Tax	10.2	11.3	8.6	17.7	11.1	14.2	10.4	19.7	13.3	18.8	13.1	23.6
+ Deferred Tax	-0.1	0.4	0.4	-0.3	-0.8	1.3	0.5	0.0	-0.9	-0.2	-1.1	-0.4
Tax Expense	10.0	11.6	9.0	17.4	10.4	15.5	10.9	19.7	12.5	18.6	12.0	23.2
Net Income	23.9	24.6	21.4	46.9	28.4	43.4	26.5	57.2	36.5	53.4	33.0	72.4
+ Net Income — Continuing Ops	23.9	24.6	21.4	46.9	28.4	43.4	26.5	57.2	36.5	53.4	33.0	72.4
+ Other Comprehensive Income	-0.3	-0.1	0.1	-1.0	0.4	0.3	-0.4	1.2	0.1	1.6	-0.1	0.6
Total Comprehensive Income	23.7	24.5	21.5	45.8	28.7	43.6	26.1	58.4	36.7	55.1	32.9	73.0
Net Income to Common	23.5	24.1	20.7	46.1	27.8	42.6	25.8	56.7	35.9	52.8	32.3	71.8
Minority Interest	0.5	0.5	0.6	0.8	0.6	0.8	0.7	0.5	0.6	0.6	0.7	0.5
Per Share
Basic EPS	7.88	8.07	6.94	15.42	9.30	14.24	8.61	18.90	11.96	17.58	10.73	23.88
Diluted EPS	7.85	8.03	6.91	15.36	9.24	14.17	8.57	18.81	11.91	17.51	10.70	23.82
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.3	-0.4	1.2	0.1	1.6	-0.1	0.6
+ Items NOT to be Reclassified to P&L	-0.4	-0.2	0.1	-0.5	-0.3	0.4	-0.4	0.1	-0.1	0.3	-0.3	0.3
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.1	-0.1	0.0	-0.0	0.1	-0.0	0.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.3	-0.0	0.6	-0.1	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	0.0	-0.1	0.0	0.1	0.6	-0.1	-0.1	1.1	0.2	1.4	0.2	0.4
Comprehensive Income — Owners of Parent	23.2	24.1	20.9	45.0	28.2	42.9	25.4	57.8	36.1	54.4	32.1	72.5
Comprehensive Income — Non-controlling Interests	0.5	0.4	0.7	0.8	0.5	0.8	0.7	0.6	0.6	0.6	0.8	0.5
Per Share — as-filed variants
Basic EPS — Continuing Operations	7.88	8.07	6.94	15.42	9.30	14.24	8.61	18.90	11.96	17.58	10.73	23.88
Diluted EPS — Continuing Operations	7.85	8.03	6.91	15.36	9.24	14.17	8.57	18.81	11.91	17.51	10.70	23.82
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	34.0	36.2	30.4	64.2	38.7	58.9	37.4	76.9	49.0	72.0	45.0	95.6
Net Income Adj (tax-effected)	23.9	24.6	21.4	46.9	28.4	43.4	26.5	57.2	36.5	53.4	33.0	72.4
EPS Adj	7.88	8.07	6.94	15.42	9.30	14.24	8.61	18.90	11.96	17.58	10.73	23.88
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	29.8	29.9	29.9	29.9	29.9	29.9	30.0	30.0	30.0	30.0	30.1	30.1

CARE Ratings quarterly results

Every quarter

CARE Ratings Limited

CARE Ratings Q2 FY27 results (July–September 2026)

Q2 FY27 at a glance · consolidated

Questions